CONMED Corporation Announces Quarterly Cash Dividend
CONMED (NYSE: CNMD) has announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share. The dividend will be paid on January 3, 2025, to shareholders of record as of December 20, 2024. The dividend declaration was made on December 9, 2024.
CONMED (NYSE: CNMD) ha annunciato che il suo Consiglio di Amministrazione ha dichiarato un dividendo in contante trimestrale di $0,20 per azione. Il dividendo sarà pagato il 3 gennaio 2025, agli azionisti registrati al 20 dicembre 2024. La dichiarazione del dividendo è stata fatta il 9 dicembre 2024.
CONMED (NYSE: CNMD) ha anunciado que su Junta Directiva ha declarado un dividendo en efectivo trimestral de $0.20 por acción. El dividendo se pagará el 3 de enero de 2025 a los accionistas registrados a partir del 20 de diciembre de 2024. La declaración del dividendo se realizó el 9 de diciembre de 2024.
CONMED (NYSE: CNMD)는 이사회가 주당 $0.20의 분기 현금 배당금을 선언했다고 발표했습니다. 이 배당금은 2025년 1월 3일에 2024년 12월 20일 기준 주주에게 지급됩니다. 배당금 선언은 2024년 12월 9일에 이루어졌습니다.
CONMED (NYSE: CNMD) a annoncé que son Conseil d'Administration a déclaré un dividende en espèces trimestriel de 0,20 $ par action. Le dividende sera payé le 3 janvier 2025 aux actionnaires inscrits au 20 décembre 2024. La déclaration du dividende a été faite le 9 décembre 2024.
CONMED (NYSE: CNMD) hat bekannt gegeben, dass der Vorstand eine vierteljährliche Bar-Dividende von 0,20 USD pro Aktie erklärt hat. Die Dividende wird am 3. Januar 2025 an Aktionäre ausgezahlt, die am 20. Dezember 2024 im Register stehen. Die Erklärung der Dividende erfolgte am 9. Dezember 2024.
- Maintains consistent quarterly dividend payment of $0.20 per share
- Demonstrates financial stability and commitment to shareholder returns
- None.
About CONMED Corporation
CONMED is a medical technology company that provides devices and equipment for surgical procedures. The Company’s products are used by surgeons and other healthcare professionals in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. For more information, visit www.conmed.com.
Forward-Looking Statements
This press release may contain forward-looking statements based on certain assumptions and contingencies that involve risks and uncertainties, which could cause actual results, performance, or trends to differ materially from those expressed in the forward-looking statements herein or in previous disclosures. For example, in addition to general industry and economic conditions, factors that could cause actual results to differ materially from those in the forward-looking statements may include, but are not limited to the risk factors discussed in the Company's Annual Report on Form 10-K for the full year ended December 31, 2023, listed under the heading Forward-Looking Statements in the Company’s most recently filed Form 10-Q and other risks and uncertainties, which may be detailed from time to time in reports filed by CONMED with the SEC. Any and all forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and relate to the Company’s performance on a going-forward basis. The Company believes that all forward-looking statements made by it have a reasonable basis, but there can be no assurance that management’s expectations, beliefs or projections as expressed in the forward-looking statements will actually occur or prove to be correct.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241210189287/en/
CONMED Corporation
Todd Garner
Chief Financial Officer
727-214-2975
ToddGarner@conmed.com
Source: CONMED Corporation
FAQ
What is CONMED's (CNMD) dividend amount for Q1 2025?
When is CONMED's (CNMD) next dividend payment date?
What is the record date for CONMED's (CNMD) latest dividend?
When did CONMED (CNMD) announce its latest quarterly dividend?
